Cover image of the article: Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings

Image Credit:Int J Cancer Manag

Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings

Authors

Mashaallah Babashahi1, Mitra Mehrazma2,*, Seyed Javad Nasiri3, Farid Azizi Jalilian4, Mostafa Rezaei-Tavirani5
1Dept. of Pathology, Iran University of Medical Sciences, Tehran, Iran
2Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran
3Dept. of Pathology , Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran
4Dept. of Medical Microbiology, Ilam University of Medical Sciences, Ilam, Iran
5Proteomics Research Center, ShahidBeheshti University of Medical Sciences, Tehran, Iran
*Corresponding Author: Corresponding author: Mitra Mehrazma, Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran, Tel: +98-2122222041-5, E-mail: Email: mitmehr@yahoo.com

International Journal of Cancer Management:Vol. 6, issue 3; e80429
Published online:Sep 30, 2013
Article type:Research Article
Received:Jan 02, 2013
Accepted:Feb 14, 2013
How to Cite:Babashahi M, Mehrazma M, Nasiri SJ, Azizi Jalilian F, Rezaei-Tavirani M. Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings. Int J Cancer Manag. 2013;6(3):e80429. doi:

Abstract

Background: Wilms' tumor is an emberyonal tumor arising from remnants of immature renal tissue. Her2/neu is an onco-protein which mediates cellular proliferation, differentiation and survival.

Methods: In the current study, we analyzed Her2/neu expression in 40 Wilms' tumors. The clinico-demographic data of 40 patients with Wilms' tumor were retrieved. Immunohistochemical staining for HER2/neu was performed. Her2/neuimmunoreactivity was evaluated by Canadian Consensus 2007 scoring system.

Results: Among the 38 specimens with epithelial component, 68.5% were positive for Her2/neu, whereas there was immunoreactivity in 37% of 38 blastemal, and 12% of 31 stromal components. The Her2/neu expression was significantly higher in early stages (81.5%) than in advanced stages (36.4%) in epithelial component, but not in other components.

Conclusion: This study suggested that Her2/neuexpression is associated with epithelial cell differentiation accompanied by lower stages of tumor. No significant relationship was found between Her2/neu positivity and tumor size and patient's age and gender.

Highlights

Fulltext

The Full text is available in PDF.

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

6
May
2017
Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors

Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors

Nesa Sayadnejad,
Alireza Firouzjahi,
Shahryar Shafaee,
Hannaneh Golshahi,
Zahra Sokouti,
Hemmat Gholinia
,et al.

Sayadnejad N, Firouzjahi A, Shafaee S, Golshahi H, Sokouti Z, et al. Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors. Int J Cancer Manag. 2017;10(5):e5700. doi: https://doi.org/10.5812/ijcm.5700

18
Sep
2024
Adult Uterine Wilm’s Tumor Miss-interpreted as Carcinosarcoma: A Case Report

Adult Uterine Wilm’s Tumor Miss-interpreted as Carcinosarcoma: A Case Report

Narges Izadi-Mood,
Fatemeh Nili,
Soheila Sarmadi,
Elham Mirzaian

Izadi-Mood N, Nili F, Sarmadi S, Mirzaian E. Adult Uterine Wilm’s Tumor Miss-interpreted as Carcinosarcoma: A Case Report. Int J Cancer Manag. 2024;17(1):e147330. doi: https://doi.org/10.5812/ijcm-147330

30
Dec
2011
The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas

The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas

Jamshid Ansari,
A Chehrei,
M Amini,
MH Sanei

Ansari J, Chehrei A, Amini M, Sanei M. The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas. Int J Cancer Manag. 2011;4(4):e80782. doi:

13
Jul
2019
Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables

Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables

Fariba Binesh,
Amirmasoud Homayon,
Hassanali Vahedian Ardekani,
Sedighe Vaziribozorg,
Seyed Hossein Shahcheraghi

Binesh F, Homayon A, Vahedian Ardekani H, Vaziribozorg S, Shahcheraghi SH. Investigation of Equivocal Expression of HER2 Gene by Immunohistochemistry in Patients with Invasive Breast Ductal Cancer Confirmed by CISH or FISH and Its Relationship with Clinicopathologic Variables. Jentashapir J Cell Mol Biol. 2019;9(6):e89002. doi: https://doi.org/10.5812/jjhr.89002

28
Sep
2016
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

Ali Taghizadeh Kermani,
Rosita Vakili,
Samaneh Dadkhah,
Amir Hossein Jafarian,
Reza Bagheri

Taghizadeh Kermani A, Vakili R, Dadkhah S, Jafarian AH, Bagheri R. HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features. Int J Cancer Manag. 2016;9(5):e5007. doi: https://doi.org/10.17795/ijcp-5007

More by these authors

Mashaallah BabashahiPubMedScholar
Mitra MehrazmaPubMedScholar
Seyed Javad NasiriPubMedScholar
Farid Azizi JalilianPubMedScholar
Mostafa Rezaei-TaviraniPubMedScholar
Share
Cited by
Metrics